Published on March 13, 2014
Autologous Chondrocyte Transplantation Dr. Babloo
Chondral Injuries Commonly these injuries heal by scar tissue formation :
- Arthroscopic Debridement : - Arthroscopic lavage - Subchondral drilling - Microfracture Marrow stimulation techniques - Abrasion arthroplasty to induce the growth of fibrocartilage into the chondral defect. Treatment options
Stages of ACI healing Healing process has several stages. They include the • proliferative stage (0 to 6 weeks), • the transition stage (7 to 12 weeks), and • a remodeling and maturation stage which occurs over a prolonged period (13 weeks to 3 years)
Proliferative stage • During this stage, a primitive cell response occurs with tissue fill of the defect and poor integration to underlying bone or adjacent cartilage. • Mostly type I and some type II collagen is produced. • The tissue is soft and jelly-like and easily damaged
Transition phase • This marks the production of type II collagen framework and the early production of proteoglycans. • The proteoglycans, which form the matrix, help imbibe water to give cartilage its viscoelastic properties. • The tissue is not yet firm or well integrated and has the consistency of a firm gelatin. • It is milkable when probed with an arthroscopic nerve hook, indicating incomplete integration to underlying bone
Stage of remodeling and maturation • The matrix proteins cross-link and stabilize in large aggregates. • The collagen framework reorganizes so as to integrate into the subchondral bone and form arcades of Benninghoff. • Usually by 4 to 6 months, the tissue has firmed up to a putty-like consistency and is integrated to the underlying bone
• At this stage, patients experience good symptom relief • During this stage excessive activity may cause repair tissue degeneration or continued improvement in remodeling • Hence, the concept of a time course of healing is critical during the rehabilitation phase of ACT
Indications for ACT • Symptomatic full-thickness chondral injury of the femoral articular surface (femoral weight- bearing condyles and sulcus or trochlea) in a physiologically young (<45 years) patient who is compliant with the rehabilitation protocol • osteochondritis dissecans (OCD)
• Results of chondral injuries of the patella and tibia (improved in 70% to 80% of patients) are not as consistently high as those of the femoral weight-bearing condyles and trochlea (85% to 90% improved) • ACT is not FDA approved as a treatment for OA, that is, bipolar chondral injuries with radiographic weight-bearing joint space loss
Pre-requisites for surgery • Appropriate biomechanical alignment • Ligamentous stability • Range of motion
Not recommended for patients who have : • an unstable knee • in children • in any joint other than knee.
Clinical examination • Assessing subtle PF maltracking is important because this may become more pronounced and symptomatic after arthrotomy, which may adversely affect the treatment outcome of a trochlea or patellar ACT • Assessment of predisposing factors for cartilage injury and degeneration may affect the prognostic outcome.
• These may include cruciate ligament insufficiency, genu varus or valgus, obesity, bone deficiency (AVN, OCD, and degenerative or ganglion bone cysts), inflammatory arthropathy, and familial osteoarthropathy • These must be assessed so that they may be either corrected in a staged or concomitant fashion with ACT
Investigations Wt bearing xray and skyline views • Evidence of joint space narrowing 50% with osteophyte formation, subchondral bony sclerosis or cyst formation eliminates patients from treatment (ie, if bone on bone changes are present)
MRI MRI scanning, while helpful for soft-tissue evaluation of meniscal or ligamentous injury as well as assessment of bone bruises and osteonecrosis, does not have a high sensitivity and specificity (75% to 93%) for determining the extent of a chondral injury or subtle chondromalacia changes.
The gold standard for determining whether a symptomatic patient is a candidate for ACT are normal radiographs, accompanied by an arthroscopic assessment showing focal pathology
A’scopy and Cartilage Biopsy • Extent of lesion, Menisci, AP length of lesion • Quality and thickness of the surrounding articular cartilage will determine whether healthy cartilage will be available for periosteal suturing or a non-contained chondral injury will require suturing through synovium or small drill holes through the bone.
• The most commonly chosen site for biopsy is the superior medial edge of the trochlea • Superior lateral femoral condyle • lateral intercondylar notch • superior transverse trochlea margin adjacent to the supracondylar synovium
• Approximately 200 to 300 mg of articular cartilage (approximately 5 mm wide and 1 cm long) is required for enzymatic digestion for cell culturing. • This contains approximately 2 to 3 lakh cells, which may be enzymatically digested and grown to approximately 120 lakh cells per 0.4 mL of culture media per implantation vial.
• After in-vitro expansion of cells 3 to 5 weeks later, a suitable number and volume of cells (usually one vial per each 4 to 6 sq cm defect) will be grown to accommodate the defect size required • Can be stored upto 2 years
Implantation of Autologous Chondrocytes Open implantation include arthrotomy, defect preparation, periosteum procurement from the tibia or femur, periosteum fixation, periosteum water-tight integrity testing, autologous or allogeneic fibrin glue sealant, chondrocyte implantation and wound closure
MACI • Matrix induced ACI • Cultured chondrocytes seeded in bilayered typeI/III collagen membrane • Implanted using fibrin glue
Rehabilitation goals ● Aggressive ROM exercises to enhance chondrocyte regeneration and decrease the likelihood of intraarticular adhesions ●Touch-weight bearing for 6 wks and full by 12 weeks to prevent periosteal overload and central degeneration or delamination of a weight bearing graft ● Isometric and gentle functional muscle exercises to regain muscle tone and prevent atrophy
• CPM is instituted as soon as cell attachment has occurred, usually 6 hours after surgery • This is utilized for approximately 6 to 8 hours daily for up to 6 weeks after surgery • Initially it is used for a range of 0° to 40° maximum. CPM from 40° to 70° is not recommended because maximal PF contact forces occur in this range.
• CPM for defects of trochlear defects is less vigorous • The remainder of the motion is obtained by the patient dangling a leg over the edge of the bed to regain further motion • On average, it takes 4 to 4 1/2 months for patients to discard their supports and walk comfortably
• Running is not permitted until graft hardness becomes similar to adjacent cartilage, which takes approximately 9 to 12 months • Kneeling and squatting are not permitted until 12 to 18 months after surgery • Osteochondritis dissecans may take 18 to 24 months.
Advantages • Can produce hyaline-like cartilage. • Can fill defects regardless of size with functional repair tissue. • Moderate to large defects that have failed previous intervention. • Repair tissue which matures, rather than deteriorates over time. • Expected outcome • Return to previous level of functioning
Disadvantages • More invasive • Expense • Longer recovery • Overall failure rate is at present quoted as being 10%.
Complications • Incomplete periosteal graft incorporation to host cartilage and hypertrophic graft edge response. • Clinically, this usually manifests as a proliferative hypertrophic periosteal healing response between 3 and 7 months after surgery • Intra-articular adhesions with resultant stiffness are uncommon • Post-op hematoma, hypertrophic synovitis
Autologous chondrocyte implantation (ACI, ATC code M09) is a biomedical treatment that repairs damages in articular cartilage. ACI provides pain relief ...
Autologous chondrocyte implantation (ACI) surgery: what it is, post op treatment and restrictions, time before light and full sports activities, success rate.
Aetna considers autologous chondrocyte implants experimental and investigational for patellar or talar lesions, or lesions of other joints (e.g., hip and ...
Autologous Chondrocyte Implantation (ACI): How It Works. 1. How cartilage works in a healthy knee . Cartilage is a form of extracellular matrix secreted by ...
Autologous chondrocyte implantation, or ACI, is a procedure that was developed in the late 1980s to treat areas of cartilage damage in the knee.
Free E-newsletter Subscribe to Housecall. Our general interest e-newsletter keeps you up to date on a wide variety of health topics. Sign up now
1. J Bone Joint Surg Am. 2010 Sep 15;92(12):2220-33. doi: 10.2106/JBJS.J.00049. Autologous chondrocyte implantation: a systematic review. Harris JD(1 ...
Standard of Care: Autologous Chondrocyte Implantation (ACI) Physical therapy management of the patient s/p ACI. 3 athletic activities in 12 to 18 months.
Autologous Chondrocyte Implantation for Chondral Defects of the Knee . Tom Minas, MD, MS Department of Orthopaedic ...
Autologous chondrocyte implanation repairs cartilage damage in young and restores them to normalcy, avoiding a knee replacement.